Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

Z. Li; F. Stölzel; K. Onel; M. Sukhanova; M. K. Mirza; K. L. Yap; O. Borinets; R. A. Larson; W. Stock; M. M. Sasaki; L. Joseph; G. Raca

doi:10.1038/leu.2015.81

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

Z. Li^*, F. Stölzel, K. Onel, M. Sukhanova, M. K. Mirza, K. L. Yap, O. Borinets, R. A. Larson, W. Stock, M. M. Sasaki, L. Joseph, G. Raca

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Letter › peer-review

33 Scopus citations

Original language	English (US)
Pages (from-to)	2113-2116
Number of pages	4
Journal	Leukemia
Volume	29
Issue number	10
DOIs	https://doi.org/10.1038/leu.2015.81
State	Published - Oct 1 2015

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2015.81

Cite this

@article{66e8be0bcce342ecb9a453ce7f013163,

title = "Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma",

author = "Z. Li and F. St{\"o}lzel and K. Onel and M. Sukhanova and Mirza, {M. K.} and Yap, {K. L.} and O. Borinets and Larson, {R. A.} and W. Stock and Sasaki, {M. M.} and L. Joseph and G. Raca",

note = "Funding Information: This work was funded by the American Cancer Society Institutional Research Grant (#IRG-58-004) and the University of Chicago Comprehensive Cancer Center Support Grant (#P30 CA14599). Funding Information: Contra el C{\'a}ncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.",

year = "2015",

month = oct,

day = "1",

doi = "10.1038/leu.2015.81",

language = "English (US)",

volume = "29",

pages = "2113--2116",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

AU - Li, Z.

AU - Stölzel, F.

AU - Onel, K.

AU - Sukhanova, M.

AU - Mirza, M. K.

AU - Yap, K. L.

AU - Borinets, O.

AU - Larson, R. A.

AU - Stock, W.

AU - Sasaki, M. M.

AU - Joseph, L.

AU - Raca, G.

N1 - Funding Information: This work was funded by the American Cancer Society Institutional Research Grant (#IRG-58-004) and the University of Chicago Comprehensive Cancer Center Support Grant (#P30 CA14599). Funding Information: Contra el Cáncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.

PY - 2015/10/1

Y1 - 2015/10/1

UR - http://www.scopus.com/inward/record.url?scp=84943587079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943587079&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.81

DO - 10.1038/leu.2015.81

M3 - Letter

C2 - 25787914

AN - SCOPUS:84943587079

SN - 0887-6924

VL - 29

SP - 2113

EP - 2116

JO - Leukemia

JF - Leukemia

IS - 10

ER -

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this